Federated Hermes’s Xeris Biopharma Holdings XERS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.97M	Buy	856,813 +1,925	+0.2%	+$12.8K	0.01%	803
2025 Q4	$6.71M	Buy	854,888 +150,505	+21%	+$1.18M	0.01%	729
2025 Q3	$5.73M	Buy	704,383 +13,002	+2%	+$86.4K	0.01%	709
2025 Q2	$3.23M	Buy	691,381 +3,598	+0.5%	+$16.5K	0.01%	838
2025 Q1	$3.78M	Buy	687,783 +685,906	+36,543%	+$2.77M	0.01%	782
2024 Q4	$6.36K	Buy	1,877 +1,696	+937%	+$5.46K	﹤0.01%	1878
2024 Q3	$516	Buy	+181	New	+$465	﹤0.01%	2000
2023 Q3	–	Sell	-44,839	Closed	-$117K	–	2213
2023 Q2	$117K	Buy	+44,839	New	+$114K	﹤0.01%	1606
2021 Q2	–	Sell	-300,000	Closed	-$1.35M	–	2350
2021 Q1	$1.35M	Hold	300,000	–	–	﹤0.01%	1256
2020 Q4	$1.48M	Hold	300,000	–	–	﹤0.01%	1181
2020 Q3	$1.78M	Hold	300,000	–	–	﹤0.01%	1041
2020 Q2	$798K	Hold	300,000	–	–	﹤0.01%	1327
2020 Q1	$585K	Hold	300,000	–	–	﹤0.01%	1332
2019 Q4	$2.12M	Hold	300,000	–	–	﹤0.01%	1011
2019 Q3	$2.95M	Hold	300,000	–	–	0.01%	915
2019 Q2	$3.43M	Hold	300,000	–	–	0.01%	901
2019 Q1	$3.01M	Hold	300,000	–	–	0.01%	916
2018 Q4	$5.1M	Hold	300,000	–	–	0.01%	730
2018 Q3	$5.27M	Hold	300,000	–	–	0.01%	790
2018 Q2	$5.69M	Buy	+300,000	New	+$5.83M	0.02%	643